Enhancing antitumor immunity in Lewis lung cancer through plasma-treated medium-induced activation of dendritic cells
Authors:
Open Access
- 23 November 2024
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-16
Abstract
Recently, atmospheric non-thermal plasma jet-treated medium (PTM) has been recognized as a novel strategy in cancer therapy and lymphocyte activation. However, PTM has limitations in inducing a robust antitumor-immune response. This study demonstrated that PTM treatment inhibited tumor progression by activating dendritic cells (DCs). In this study, we investigated the effects of PTM on selective cytotoxicity and intracellular reactive oxygen species (ROS) generation and oxidative stress-mediated signaling (e.g., glutathione peroxidase, catalase) using respective fluorescence probes in Lewis lung cancer (LLC) cells. Then, the PTM affects the expression of interferon-gamma (IFN)-γ-induced programmed death-ligand 1 (PD-L1) and inhibition of signal transducer and activator of transcription 1 (STAT1) in LLC cells using immunoblotting. Additionally, PTM effects on the tumor cell’s death and activation of DCs were done by co-culturing DCs with or without tumor cells. Further, a mouse model was used to evaluate the synergistic antitumor effects of PTM and DCs where tumors are grown under the skin. PTM-exposed tumor cells increase intracellular superoxide production, enhancing ROS generation and leading to cancer immunogenic cell death. In addition, PTM suppresses IFN-γ-induced PD-L1 expression and STAT1 activation in tumor cells. The activation of DCs induced by PTM is downregulated when these cells are co-cultured with tumor cells. In vivo, intraperitoneal injection of PTM-activated DCs, as a synergistic agent to intertumoral PTM treatment, led to increased CD4+ and CD8+ T cell infiltration into the tumor and spleen and eventually decreased tumor growth. Overall, this research introduces a promising avenue for improving lung cancer treatment using PTM to stimulate an immune response and induce cell death in tumor cells. Further studies will be essential to validate these findings and explore clinical applications.Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-1156)
- korea, ICT and future planning (2020R1A2C1008826)
This publication has 54 references indexed in Scilit:
- Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial–nuclear networkFree Radical Biology and Medicine, 2015
- Immunogenic cell deathThe International Journal of Developmental Biology, 2015
- Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2014
- Non-small-cell lung cancers: a heterogeneous set of diseasesNature Reviews Cancer, 2014
- Modulatory effects of low-dose hydrogen peroxide on the function of human plasmacytoid dendritic cellsFree Radical Biology and Medicine, 2011
- Cytotoxic Dendritic Cells Generated from Cancer PatientsThe Journal of Immunology, 2011
- Observation of dendritic cell morphology under light, phase-contrast or confocal laser scanning microscopy.2010
- Regulation of Interferon‐γ During Innate and Adaptive Immune Responses2007
- Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology, 2005
- Dendritic cells and the control of immunityNature, 1998